title: Pemphigus treatment in Japan.
abstract: Pemphigus is a group of autoimmune blistering diseases characterized by blisters and erosive lesions on the skin and mucous membranes due to loss of cell and cell adhesion of keratinocytes. In 2010, new Japanese guidelines for the management of pemphigus were published for dermatologists. Systemic corticosteroids are the gold standard and the first choice of treatment of pemphigus.
authors.affiliation: Department of Dermatology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan. tanikawa@sc.itc.keio.ac.jp
authors.forename: Akiko
authors.initials: A
authors.lastname: Tanikawa
authors.forename: Masayuki
authors.initials: M
authors.lastname: Amagai
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008297:Male; D010392:Pemphigus / Q000188:drug therapy* / Q000453:epidemiology; D017410:Practice Guidelines as Topic
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents